Anita M. Dreyer

Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies

Andrew T. McGuire, Sam Hoot, Anita M. Dreyer et al. · The Journal of Experimental Medicine · 2013 · 316 citations · Full text

Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial

Angela Huttner, Christoph Hatz, Germie van den Dobbelsteen et al. · The Lancet Infectious Diseases · 2017 · 201 citations

Vaccination, Vaccine Safety, Urology +6

Antigen modification regulates competition of broad and narrow neutralizing HIV antibodies

Andrew T. McGuire, Anita M. Dreyer, Sara Carbonetti et al. · Science · 2014 · 125 citations

Immunology, Antigen Processing, Viral Structural Protein +18

Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection

Kawsar R. Talaat, Cristina Alaimo, Patricia Martín et al. · EBioMedicine · 2021 · 78 citations · Full text

Passive Immunoprotection of <i>Plasmodium falciparum</i>-Infected Mice Designates the CyRPA as Candidate Malaria Vaccine Antigen

Anita M. Dreyer, Hugues Matile, Petros Papastogiannidis et al. · The Journal of Immunology · 2012 · 75 citations